MK
Mandanna Katimada Balakrishna
About Mandanna Katimada Balakrishna
Data last updated:
Mandanna Katimada Balakrishna is a Director at Tamara Medical Services Private Limited (since 2024) and Designated Partner at Tamara Healthcare Services Llp (since 2023). The companies operate in Healthcare.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 30 Mar 2024 | 2024 | Active | ||
| Designated Partner | 17 May 2023 | 2023 | Active |
Board colleagues of Mandanna Katimada Balakrishna
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ashik Aramanamada Madaiah | 10167080 | Tamara Medical Services Private Limited , Tamara Healthcare Services Llp | Director |
| Rangappa Sureshkumar | 10571984 | Tamara Medical Services Private Limited | Director |
| Rejeesh Thoduvil Kandoth | 10571983 | Tamara Medical Services Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mandanna Katimada Balakrishna
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mandanna Katimada Balakrishna
Mandanna Katimada Balakrishna currently holds 2 directorships: Tamara Medical Services Private Limited (Director, since 30 Mar 2024); Tamara Healthcare Services Llp (Designated Partner, since 17 May 2023).
Mandanna Katimada Balakrishna was first appointed on 17 May 2023 as Designated Partner at Tamara Healthcare Services Llp. The most recent appointment on record is 30 Mar 2024 at Tamara Medical Services Private Limited.
The current boards of Mandanna Katimada Balakrishna's companies include Ashik Aramanamada Madaiah (Tamara Medical Services Private Limited), Rangappa Sureshkumar (Tamara Medical Services Private Limited), Rejeesh Thoduvil Kandoth (Tamara Medical Services Private Limited).